CollPlant Biotechnologies
CLGN
CLGN
21 hedge funds and large institutions have $10.7M invested in CollPlant Biotechnologies in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.51% less ownership
Funds ownership: 15.78% → 14.27% (-1.5%)
25% less capital invested
Capital invested by funds: $14.3M → $10.7M (-$3.61M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
21
Holding in Top 10
1
Calls
–
Puts
$3K
Top Buyers
| 1 | +$388K | |
| 2 | +$131K | |
| 3 | +$90K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$33K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
Top Sellers
| 1 | -$2.19M | |
| 2 | -$116K | |
| 3 | -$43.7K | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$23.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |